The list prices of the top 25 drugs with the highest Medicare Part D spend that are not subject to drug price negotiations ...

As the U.S. stock market navigates mixed performance amid fluctuating interest rate expectations and economic data releases, investors are keenly observing potential opportunities in various sectors.